CN114868924A - Composition based on D-ribose and amino acid and application thereof - Google Patents
Composition based on D-ribose and amino acid and application thereof Download PDFInfo
- Publication number
- CN114868924A CN114868924A CN202210519135.3A CN202210519135A CN114868924A CN 114868924 A CN114868924 A CN 114868924A CN 202210519135 A CN202210519135 A CN 202210519135A CN 114868924 A CN114868924 A CN 114868924A
- Authority
- CN
- China
- Prior art keywords
- component
- ribose
- amino acid
- parts
- based composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 title claims abstract description 121
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 title claims abstract description 62
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 43
- 229940024606 amino acid Drugs 0.000 claims abstract description 42
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 37
- 235000020510 functional beverage Nutrition 0.000 claims abstract description 31
- 230000000694 effects Effects 0.000 claims abstract description 20
- 244000269722 Thea sinensis Species 0.000 claims abstract description 18
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims abstract description 18
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960003080 taurine Drugs 0.000 claims abstract description 18
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 17
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 17
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000004472 Lysine Substances 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000004473 Threonine Substances 0.000 claims abstract description 11
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 10
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 10
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 10
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims abstract description 10
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 10
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 10
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims abstract description 10
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 10
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960000310 isoleucine Drugs 0.000 claims abstract description 10
- 229930182817 methionine Natural products 0.000 claims abstract description 10
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004474 valine Substances 0.000 claims abstract description 10
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 9
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 9
- 229960001948 caffeine Drugs 0.000 claims abstract description 9
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000020733 paullinia cupana extract Nutrition 0.000 claims abstract description 8
- 125000003603 D-ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 230000002929 anti-fatigue Effects 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 2
- 235000019449 other food additives Nutrition 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 235000013616 tea Nutrition 0.000 description 17
- 229960002160 maltose Drugs 0.000 description 16
- 239000002994 raw material Substances 0.000 description 14
- 235000020776 essential amino acid Nutrition 0.000 description 8
- 239000003797 essential amino acid Substances 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 240000003444 Paullinia cupana Species 0.000 description 4
- 235000000556 Paullinia cupana Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- 241000190633 Cordyceps Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- QCOZYUGXYJSINC-UHFFFAOYSA-N 1,3,7-trimethylpurine-2,6-dione Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C.CN1C(=O)N(C)C(=O)C2=C1N=CN2C QCOZYUGXYJSINC-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a composition based on D-ribose and amino acid and application thereof. The composition comprises: a first component, a second component, a third component, a fourth component; wherein the first component is D-ribose, the second component is one or more of lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine or tryptophan, the third component is one or more of maltose or taurine, and the fourth component is tea extract; the composition based on D-ribose and amino acid necessarily contains a first component and a second component, and one or two components of a third component and a fourth component, and does not contain any one of caffeine or guarana extract. The composition has reasonable formula and scientific dosage proportion, has obvious effects of rapidly supplementing physical strength and resisting fatigue, also has the advantages of easy preparation, low production cost and the like, and is suitable for being used as a functional beverage for people who need to rapidly supplement physical strength and resist fatigue.
Description
Technical Field
The invention relates to the technical field of food, in particular to a composition based on D-ribose and amino acid and application thereof.
Background
Fatigue is a phenomenon in which the efficiency of people decreases after continuous learning, work or exercise. Relief or even elimination of fatigue can be achieved by adequate sleep and rest, but this often requires longer rest times; in the case of needing to supplement physical strength rapidly (such as competitive sports, overtime and the like), the physical strength can be recovered rapidly by taking medicines or drinks with the functions of resisting fatigue. However, most of these products are either not effective or involve stimulant ingredients and are not suitable for long-term consumption as functional beverages. Among functional drinks having an anti-fatigue effect, some are not exact, and some contain Caffeine (Caffeine) and Guarana (Guarana, rare fruit growing in the conayamason conk, whose main component is Guarana, chemical components and functions are similar to Caffeine). Guarana has similar side effects to caffeine, is easy to cause palpitation, anxiety, stomachache and accelerated heartbeat, is easy to generate psychological dependence after long-term administration, and is easy to cause insomnia after long-term excitation. CN101961345A discloses a pharmaceutical composition with anti-fatigue effect, which comprises cordyceps polysaccharide or fermented cordyceps sinensis liquid, D-ribose and taurine. However, the patent takes cordyceps polysaccharide or fermented cordyceps fungus liquid as a main component, has high cost and is not suitable for being used as a functional beverage for mass consumption. CN102150724A discloses a functional mixture for refreshing and relieving physical and visual fatigue, which contains more than ten ingredients of taurine, caffeine, green tea extract, American ginseng extract, guarana extract, ginkgo leaf extract, medlar extract and the like. CN103816256B reports a physiologically functional composition comprising D-ribose, taurine and guarana extract or green coffee bean extract. Although it has a certain anti-fatigue effect, both contain caffeine or guarana extract, etc., which have significant side effects.
Disclosure of Invention
The invention aims to overcome the technical defects, provides a composition based on D-ribose and amino acid and application thereof, and solves the technical problems that a functional composition with an anti-fatigue effect in the prior art is poor in anti-fatigue effect or contains caffeine or guarana extracts.
The first aspect of the present invention provides a composition based on D-ribose and amino acid, characterized in that it comprises: a first component, a second component, a third component, a fourth component; wherein the first component is D-ribose, the second component is one or more of lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine or tryptophan, the third component is one or more of maltose or taurine, and the fourth component is tea extract; the composition based on D-ribose and amino acid necessarily contains a first component and a second component, and one or two components of a third component and a fourth component, and does not contain any one of caffeine or guarana extract.
The second aspect of the invention provides the use of a composition based on D-ribose and amino acids as described above, for the preparation of a product having a rapid physical strength-supplementing and anti-fatigue effect.
In a third aspect, the present invention provides a functional beverage comprising the composition based on D-ribose and amino acid provided in the first aspect of the present invention.
Compared with the prior art, the invention has the beneficial effects that:
the composition has reasonable formula and scientific dosage proportion, has obvious effects of rapidly supplementing physical strength and resisting fatigue, also has the advantages of easy preparation, low production cost and the like, and is suitable for being used as a functional beverage for people who need to rapidly supplement physical strength and resist fatigue.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
In a first aspect of the present invention, there is provided a composition based on D-ribose and amino acids comprising a first component which is D-ribose, a second component which is a combination of one or more essential amino acids of 8 amino acids essential for adults, a third component which is one or a combination of maltose and taurine, and a fourth component which is a tea extract; the composition based on D-ribose and amino acid necessarily contains a first component and a second component, and one or two of a third component and a fourth component. The composition based on D-ribose and amino acids does not contain any one of caffeine or guarana extract. The composition based on D-ribose and amino acid has the effects of rapidly supplementing physical strength and resisting fatigue, and is suitable for people needing to rapidly supplement physical strength and resisting fatigue.
D-ribose is a monosaccharide containing five carbon atoms, is an important constituent of ribonucleic acid (RNA), which is a genetic material in organisms, and has a close relationship with the formation of adenosine and the regeneration of Adenosine Triphosphate (ATP). Research proves that the D-ribose is an important raw material for synthesizing an energy substance ATP by muscles, and has the advantages of relieving fatigue, enhancing body energy, improving cardiac ischemia, improving cardiac function, relieving muscle soreness and the like.
Amino acids are the most basic substances constituting life and are constituent units of proteins, and about 20 kinds of amino acids are present in the human body, and eight kinds of essential amino acids for adults include lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine, and tryptophan. In addition to the 8 adult species, the infant contains 9 essential amino acids, including histidine in addition to the eight species mentioned above. The action and efficacy of amino acids include enhancing immunity, synthesizing tissue proteins, providing energy to the body, concentrating attention, promoting sleep, helping to break down fat, and preventing cardiovascular and cerebrovascular diseases, liver diseases, kidney diseases, etc.
Taurine, also called beta-aminoethanesulfonic acid, is a sulfur-containing non-protein amino acid, has various physiological functions beneficial to human bodies, but the taurine synthesized by the human bodies is few, and the requirement of the human bodies is met mainly by taking the taurine in food.
Maltose (maltose) is a disaccharide made of two glucose units linked via an alpha-1, 4 glycosidic bond, also known as maltobiose. The effects and actions of maltose include: supplementing carbon source and energy required by organism, maintaining intestinal health, preventing hypertension, hyperlipemia and arteriosclerosis, protecting liver and preventing liver cirrhosis, etc.
Tea is a well-known healthy drink, and is called "miraculous oriental leaves" by the european elite level in the 16 th century. The tea extract also contains various beneficial components, such as tea polyphenols (with multiple effects of resisting oxidation, scavenging oxygen free radicals, resisting inflammation, reducing incidence of cardiovascular diseases, reducing blood lipid, reducing body fat formation, resisting bacteria, and changing intestinal flora ecology), tea pigment (mainly comprising chlorophyll, beta-carotene, etc., and having effects of delaying aging and caring skin), theanine (capable of improving brain function, enhancing memory and learning ability, it can be used for preventing Alzheimer's disease, Parkinson disease and autonomic nerve dysfunction), and tea polysaccharide (with effects of resisting radiation, increasing leukocyte, enhancing immunity, lowering blood sugar and gamma-aminobutyric acid (with effects of dilating blood vessel to reduce blood pressure, and can be used for adjuvant treatment of hypertension, improving cerebral blood circulation, and enhancing metabolism of brain cells).
The present inventors have conducted creative studies on the raw materials and the weight parts thereof in the above-mentioned composition based on D-ribose and amino acid, and as a result, have found that the above-mentioned functional beverage composition has various uses in rapidly recovering physical strength and resisting fatigue.
Preferably, the main raw materials of the composition based on D-ribose and amino acid are 1-10 parts by weight of a first component (D-ribose), 1-10 parts by weight of a second component (one or a combination of 8 adult essential amino acids of lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine and tryptophan), 0-30 parts by weight of a third component (one or a combination of maltose or taurine) and 0-10 parts by weight of a fourth component (tea extract), and the third component and the fourth component are not 0.
More preferably, the main raw materials of the composition based on D-ribose and amino acid are 5-10 parts by weight of a first component (D-ribose), 9-10 parts by weight of a second component (one or a combination of 8 adult essential amino acids of lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine and tryptophan), 0-20 parts by weight of a third component (one or a combination of maltose or taurine) and 0-6 parts by weight of a fourth component (tea extract), and the third component and the fourth component are not both 0.
Further, the main raw materials of the composition based on D-ribose and amino acid are 8-10 parts by weight of the first component (D-ribose), 9-10 parts by weight of the second component (one or a combination of more of the 8 essential amino acids for adults, lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine and tryptophan), and 5-6 parts by weight of the fourth component (tea extract).
Furthermore, the main raw materials of the composition based on the D-ribose and the amino acid are 8 to 10 parts by weight of a first component (D-ribose), 9 to 10 parts by weight of a second component (one or a combination of more than 8 adult essential amino acids of lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine and tryptophan), and 8 to 20 parts by weight of a third component (one or a combination of maltose and taurine).
Further, the main raw materials of the composition based on D-ribose and amino acid are 8-10 parts by weight of a first component (D-ribose), 9-10 parts by weight of a second component (one or a combination of more than 8 adult essential amino acids of lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine and tryptophan), 8-20 parts by weight of a third component (one or a combination of maltose and taurine), and 5-6 parts by weight of a fourth component (tea extract).
The second aspect of the invention provides the use of a composition based on D-ribose and amino acids as described above, for the preparation of a product having a rapid physical strength-supplementing and anti-fatigue effect.
In a third aspect, the present invention provides a functional beverage comprising the composition based on D-ribose and amino acid provided in the first aspect of the present invention.
Preferably, the concentration of the first component in the functional beverage is 0.01g/L to 2g/L, and may be, for example, 0.01g/L, 0.1g/L, 0.5g/L, 1g/L, 1.5g/L, or 2 g/L.
Preferably, the functional beverage comprises water, other food additives and auxiliary materials in addition to the above-mentioned composition based on D-ribose and amino acid, which is not limited by the present invention.
Example 1: preparation of functional beverage YL-1
Taking the following raw materials by weight: 100g of D-ribose, 90g of lysine, 200g of maltose and 50g of tea extract, adding deionized water to dissolve and dilute the D-ribose, diluting the D-ribose and the lysine to 100L, and subpackaging the solution into 200 bottles (500 ml per bottle) to obtain the functional beverage YL-1.
Example 2: preparation of functional beverage YL-2
Taking the following raw materials by weight: 100g of D-ribose, 90g of phenylalanine, 80g of taurine and 50g of tea extract, adding deionized water to dissolve and dilute the D-ribose, diluting the D-ribose to 100L, and subpackaging the solution into 200 bottles (500 ml per bottle) to obtain the functional beverage YL-2.
Example 3: preparation of functional beverage YL-3
Taking the following raw materials by weight: 50g of D-ribose, 90g of methionine, 200g of maltose and 50g of tea extract are dissolved and diluted to 100L by adding deionized water, and 200 bottles (500 ml per bottle) are subpackaged to obtain the functional beverage YL-3.
Example 4: preparation of functional beverage YL-4
Taking the following raw materials by weight: 100g of D-ribose, 30g of threonine, 30g of isoleucine, 30g of leucine, 150g of maltose and 50g of tea extract, adding deionized water to dissolve and dilute the mixture to 100L, and subpackaging the mixture into 200 bottles (500 ml per bottle) to obtain the functional beverage YL-4.
Example 5: preparation of functional beverage YL-5
Taking the following raw materials by weight: 80g of D-ribose, 40g of lysine, 30g of valine, 30g of tryptophan and 60g of tea extract, adding deionized water to dissolve and dilute the mixture to 100L, and subpackaging the mixture into 200 bottles (500 ml per bottle) to obtain the functional beverage YL-5.
Example 6: preparation of functional beverage YL-6
Taking the following raw materials by weight: 100g of D-ribose, 90g of lysine, 100g of maltose, 80g of taurine and 50g of tea extract, adding deionized water to dissolve and dilute the mixture to 100L, and subpackaging the mixture into 200 bottles (500 ml per bottle) to obtain the functional beverage YL-6.
Example 7: preparation of functional beverage YL-7
Taking the following raw materials by weight: 100g of D-ribose, 50g of lysine, 50g of threonine, 100g of maltose and 80g of taurine, adding deionized water to dissolve and dilute the mixture to 100L, and subpackaging the mixture into 200 bottles (500 ml per bottle) to obtain the functional beverage YL-7.
Test groups: mouse swimming experiment
Kunming mice with the weight of 18-22G are selected and are randomly and averagely divided into 20 groups (A-T groups), the A-G groups are sequentially irrigated with the functional beverages YL-1-YL-7 prepared in the examples 1-7, the H group is a blank control group and is irrigated with physiological saline with the same quantity as the stomach, and the I-T groups are sequentially irrigated with different single-component and multi-component functional beverages. Each mouse is 0.1ml, 1 time each day in the morning and afternoon, for 3 days. 30min after the last 1 gastric lavage, the tail root of the mouse is wrapped with a lead wire which is quite dry and has the weight of 7.5 percent, the mouse is placed in a water tank with the dry water temperature of about 25 ℃ for swimming, the time from the beginning of swimming to death of the mouse at the bottom of a sinking water is recorded, and the statistical treatment is carried out by taking seconds as a time unit, and the result is shown in table 1.
TABLE 1 swimming time comparison table after intragastric administration for each group of mice
As can be seen from the data in Table 1, compared with the group H, the group I-M with a single component and the group N-T with two components, the group A-G mice with the functional beverage prepared by the invention after gastric lavage have much better performance, which shows that the three-component and four-component distribution formula in the embodiment of the invention can play an obvious synergistic effect, and the functional beverage prepared by the invention really has obvious effects of quickly supplementing physical strength and resisting fatigue; meanwhile, when the third component contains taurine and maltose, the synergistic effect of the third component is better exerted, and the anti-fatigue effect is obviously improved.
The above-described embodiments of the present invention should not be construed as limiting the scope of the present invention. Any other corresponding changes and modifications made according to the technical idea of the present invention should be included in the protection scope of the claims of the present invention.
Claims (10)
1. A D-ribose and amino acid based composition, wherein the D-ribose and amino acid based composition comprises: a first component, a second component, a third component, a fourth component; wherein the first component is D-ribose, the second component is one or more of lysine, phenylalanine, methionine, threonine, isoleucine, leucine, valine or tryptophan, the third component is one or more of maltose or taurine, and the fourth component is tea extract; the composition based on D-ribose and amino acid necessarily contains a first component and a second component, and one or two components of a third component and a fourth component, and does not contain any one of caffeine or guarana extract.
2. The D-ribose and amino acid based composition according to claim 1, wherein said D-ribose and amino acid based composition comprises: 1-10 parts of a first component, 1-10 parts of a second component, 0-30 parts of a third component and 0-10 parts of a fourth component, wherein the third component and the fourth component are not 0.
3. The D-ribose and amino acid based composition according to claim 1, wherein said D-ribose and amino acid based composition comprises: 5-10 parts of a first component, 9-10 parts of a second component, 0-20 parts of a third component and 0-6 parts of a fourth component, wherein the third component and the fourth component are not 0.
4. The D-ribose and amino acid based composition according to claim 1, wherein said D-ribose and amino acid based composition comprises: 8-10 parts of first component, 9-10 parts of second component and 5-6 parts of fourth component.
5. The D-ribose and amino acid based composition according to claim 1, wherein said D-ribose and amino acid based composition comprises: 8-10 parts of first component, 9-10 parts of second component and 8-20 parts of third component.
6. The D-ribose and amino acid based composition according to claim 1, wherein said D-ribose and amino acid based composition comprises: 8-10 parts of first component, 9-10 parts of second component, 8-20 parts of third component and 5-6 parts of fourth component.
7. Use of a composition based on D-ribose and amino acid according to any one of claims 1 to 6, for the preparation of a product with a rapid physical strength-supplementing and anti-fatigue effect.
8. A functional beverage comprising the composition based on D-ribose and amino acid according to any one of claims 1 to 6.
9. The functional beverage according to claim 8, wherein the concentration of the first component in the functional beverage is 0.01g/L to 2 g/L.
10. The functional beverage according to claim 8, further comprising: water, other food additives and auxiliary materials.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210519135.3A CN114868924A (en) | 2022-05-13 | 2022-05-13 | Composition based on D-ribose and amino acid and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210519135.3A CN114868924A (en) | 2022-05-13 | 2022-05-13 | Composition based on D-ribose and amino acid and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114868924A true CN114868924A (en) | 2022-08-09 |
Family
ID=82676581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210519135.3A Pending CN114868924A (en) | 2022-05-13 | 2022-05-13 | Composition based on D-ribose and amino acid and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114868924A (en) |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1429113A (en) * | 2000-05-08 | 2003-07-09 | 努特里奇亚有限公司 | Nutritional preparation comprising ribose and folic acid and medical use thereof |
| US20070191287A1 (en) * | 2004-03-18 | 2007-08-16 | Michio Yamamura | D-ribose for improving depression-like symptoms |
| CN101331950A (en) * | 2008-08-05 | 2008-12-31 | 北京康比特体育科技股份有限公司 | Nutritional supplement for increasing sports break-out force |
| US20090061050A1 (en) * | 2007-09-05 | 2009-03-05 | Selzer Jonathan A | Seawater based dietary supplement product for energy and electrolyte replacement |
| CN101756206A (en) * | 2008-09-29 | 2010-06-30 | 宁小静 | Health-care food |
| CN101961345A (en) * | 2010-10-26 | 2011-02-02 | 郭景龙 | Medicinal composition having anti-fatigue function |
| CN102100805A (en) * | 2011-01-31 | 2011-06-22 | 上海东锦食品集团有限公司 | Composition for relieving physical fatigue and enhancing immunologic function, preparation method thereof and application thereof |
| CN102318795A (en) * | 2011-10-19 | 2012-01-18 | 郭景龙 | Health-care food having anti-fatigue function |
| CN103816256A (en) * | 2014-02-24 | 2014-05-28 | 成都创盛生物医学材料有限公司 | Composition with physiological functions |
| CN104997101A (en) * | 2015-07-27 | 2015-10-28 | 程柳 | Functional beverage |
| CN105341594A (en) * | 2014-08-19 | 2016-02-24 | 武汉宏博生物技术有限公司 | Sugar-free amino acid beverage |
| US20160303177A1 (en) * | 2015-04-15 | 2016-10-20 | Erroll J. Bailey | Nutritional supplement |
| US20170339972A1 (en) * | 2011-09-01 | 2017-11-30 | John C. Gilkey | Nutritional Compositions |
| CN109452651A (en) * | 2018-08-14 | 2019-03-12 | 北京恒创知远生物技术有限公司 | Endurance composition |
| CN114158669A (en) * | 2021-12-10 | 2022-03-11 | 河北氨健喜生物科技有限公司 | Solid beverage formula for improving exercise endurance and preparation method thereof |
-
2022
- 2022-05-13 CN CN202210519135.3A patent/CN114868924A/en active Pending
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1429113A (en) * | 2000-05-08 | 2003-07-09 | 努特里奇亚有限公司 | Nutritional preparation comprising ribose and folic acid and medical use thereof |
| US20070191287A1 (en) * | 2004-03-18 | 2007-08-16 | Michio Yamamura | D-ribose for improving depression-like symptoms |
| US20090061050A1 (en) * | 2007-09-05 | 2009-03-05 | Selzer Jonathan A | Seawater based dietary supplement product for energy and electrolyte replacement |
| CN101331950A (en) * | 2008-08-05 | 2008-12-31 | 北京康比特体育科技股份有限公司 | Nutritional supplement for increasing sports break-out force |
| CN101756206A (en) * | 2008-09-29 | 2010-06-30 | 宁小静 | Health-care food |
| CN101961345A (en) * | 2010-10-26 | 2011-02-02 | 郭景龙 | Medicinal composition having anti-fatigue function |
| CN102100805A (en) * | 2011-01-31 | 2011-06-22 | 上海东锦食品集团有限公司 | Composition for relieving physical fatigue and enhancing immunologic function, preparation method thereof and application thereof |
| US20170339972A1 (en) * | 2011-09-01 | 2017-11-30 | John C. Gilkey | Nutritional Compositions |
| CN102318795A (en) * | 2011-10-19 | 2012-01-18 | 郭景龙 | Health-care food having anti-fatigue function |
| CN103816256A (en) * | 2014-02-24 | 2014-05-28 | 成都创盛生物医学材料有限公司 | Composition with physiological functions |
| CN105341594A (en) * | 2014-08-19 | 2016-02-24 | 武汉宏博生物技术有限公司 | Sugar-free amino acid beverage |
| US20160303177A1 (en) * | 2015-04-15 | 2016-10-20 | Erroll J. Bailey | Nutritional supplement |
| CN104997101A (en) * | 2015-07-27 | 2015-10-28 | 程柳 | Functional beverage |
| CN109452651A (en) * | 2018-08-14 | 2019-03-12 | 北京恒创知远生物技术有限公司 | Endurance composition |
| CN114158669A (en) * | 2021-12-10 | 2022-03-11 | 河北氨健喜生物科技有限公司 | Solid beverage formula for improving exercise endurance and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8137712B2 (en) | Rehydration beverage | |
| CN102293430B (en) | Beverage with functions of antioxidation and immunity enhancing, and preparation method thereof | |
| CN101248873A (en) | Drinking food product with sight protection function | |
| AU2014292651B2 (en) | Anti-fatigue composition and use thereof | |
| CN113180165A (en) | Beautifying beverage containing sodium hyaluronate and preparation method thereof | |
| CN102160664A (en) | Nutritious drink for children | |
| CN111345411A (en) | Energy beverage for women and preparation method thereof | |
| CN112137095A (en) | Sports nutritional composition and preparation method thereof | |
| CN107455625A (en) | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | |
| CN102845795A (en) | Functional health-care beverage | |
| CN101248880B (en) | Fatigue resistant sport drink and method of preparing the same | |
| CN112602861A (en) | Basidiomycetes composite beverage for improving immunity and preparation method thereof | |
| CN104207241B (en) | A kind of integration of drinking and medicinal herbs composite health care beverage and preparation method thereof | |
| KR20100112215A (en) | A functional beverage comprising deep sea water, extract of red ginseng, extract of jujubae fructus, extract of cnidii rhizoma, extract of glycyrrhizae radix and extract of lycii fructus as main ingredients | |
| US20160129025A1 (en) | Anti-fatigue composition and use thereof | |
| CN101396115A (en) | Xylo-oligosaccharide stomach-invigorating intestine-moisturizing oral liquid and preparation method thereof | |
| CN102429302B (en) | Ginkgo-containing health drink and processing process | |
| CN105029553A (en) | Fruit juice-egg-calcium traditional Chinese medicine health beverage and preparation method thereof | |
| CN110710625A (en) | Tremella compound suspension beverage and preparation method thereof | |
| CN103829342B (en) | Functional health-care drink and preparation method thereof | |
| JPH0775536A (en) | Refreshing beverage containing qaercetin glucoside | |
| CN114868924A (en) | Composition based on D-ribose and amino acid and application thereof | |
| CN114938835A (en) | Dihydroquercetin SOD (superoxide dismutase) collagen tripeptide beverage formula | |
| KR102235563B1 (en) | Composition for fatigue recovery and sexual function improvement containing high content of arginine | |
| CN114916631A (en) | Ultrahigh-purity octacosanol-flavone composite deuterium-depleted water combined and co-refined high-energy beverage and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |